BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15366425)

  • 21. Multiglycosidorum tripterygii, a new immunosuppressant, supresses coronary arteriosclerosis after heart transplantation.
    Hachida M; Zhang X; Lu H; Hoshi H; Koyanagi H
    J Heart Lung Transplant; 1999 Mar; 18(3):248-54. PubMed ID: 10328151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.
    Richter M; Skupin M; Grabs R; Schramm D; Richter H; Olbrich HG
    J Heart Lung Transplant; 2000 Nov; 19(11):1047-55. PubMed ID: 11077221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.
    Jin H; Yang R; Gillett N; Clark RG; Ko A; Paoni NF
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):420-5. PubMed ID: 8583784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fast and reproducible vascular neointima formation in the hamster carotid artery: effects of trapidil and captopril.
    Matsuno H; Stassen JM; Hoylaerts MF; Vermylen J; Deckmyn H
    Thromb Haemost; 1995 Dec; 74(6):1591-6. PubMed ID: 8772242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of atorvastatin on the angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ) induced diabetic rats.
    Chaudagar KK; Mehta AA
    Can J Physiol Pharmacol; 2014 Apr; 92(4):338-49. PubMed ID: 24708217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effects of a novel angiotensin-converting enzyme inhibitor versus captopril on plasma angiotensins after myocardial infarction.
    Flores-Monroy J; Ferrario CM; Valencia-Hernández I; Hernández-Campos ME; Martínez-Aguilar L
    Pharmacology; 2014; 94(1-2):21-8. PubMed ID: 25171296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low molecular weight fucan prevents transplant coronaropathy in rat cardiac allograft model.
    Alkhatib B; Freguin-Bouilland C; Lallemand F; Henry JP; Litzler PY; Marie JP; Richard V; Thuillez C; Plissonnier D
    Transpl Immunol; 2006 Jun; 16(1):14-9. PubMed ID: 16701171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transplantation of bone marrow cells upregulated vascular endothelial growth factor and its receptor and improved ischemic myocardial function].
    Zhang S; Jia Z; Guo J; Zhang P; Ma K; Wang S; Liu Y; Li L; Zhou C
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):429-33. PubMed ID: 12947564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart allograft endothelial cell dysfunction. Cause, course, and consequences.
    Weis M; Pehlivanli S; von Scheidt W
    Z Kardiol; 2000; 89 Suppl 9():IX/58-62. PubMed ID: 11151795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of thrombospondin-1 and cardiac allograft vasculopathy in human cardiac allografts.
    Zhao XM; Hu Y; Miller GG; Mitchell RN; Libby P
    Circulation; 2001 Jan; 103(4):525-31. PubMed ID: 11157717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The induction of an angiogenic response in corneal myofibroblasts by platelet-activating factor (PAF).
    He J; Eastlack JP; Bazan HE
    Curr Eye Res; 2010 Dec; 35(12):1063-71. PubMed ID: 20961214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
    Azizi Y; Faghihi M; Imani A; Roghani M; Zekri A; Mobasheri MB; Rastgar T; Moghimian M
    Eur J Pharmacol; 2015 Aug; 761():101-8. PubMed ID: 25936512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels.
    Brostjan C; Gebhardt K; Gruenberger B; Steinrueck V; Zommer H; Freudenthaler H; Roka S; Gruenberger T
    Clin Cancer Res; 2008 Apr; 14(7):2065-74. PubMed ID: 18381946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Activation of the cardiac angiotensin-converting enzyme after myocardial infarction and its role in ventricular remodeling].
    Mill JG; Milanez Mda C; Busatto VC; de Moraes AC; Gomes Mda G
    Arq Bras Cardiol; 1997 Aug; 69(2):101-10. PubMed ID: 9567332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model.
    Montrucchio G; Lupia E; Battaglia E; Del Sorbo L; Boccellino M; Biancone L; Emanuelli G; Camussi G
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):80-8. PubMed ID: 10634803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of estrogen and angiotensin-converting enzyme inhibitor on vascular remodeling in ovariectomized spontaneously hypertensive rats.
    García MP; Giménez J; Serna M; Salom MG; Bonacasa B; Carbonell LF; Quesada T; Hernández I
    Menopause; 2006; 13(3):397-403. PubMed ID: 16735936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of angiogenesis by platelet-activating factor in the rat striatum.
    Tran KC; Ryu JK; McLarnon JG
    Neuroreport; 2005 Sep; 16(14):1579-83. PubMed ID: 16148749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
    Westenbrink BD; Lipsic E; van der Meer P; van der Harst P; Oeseburg H; Du Marchie Sarvaas GJ; Koster J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
    Eur Heart J; 2007 Aug; 28(16):2018-27. PubMed ID: 17576662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat.
    Lapointe N; Blais C; Adam A; Parker T; Sirois MG; Gosselin H; Clément R; Rouleau JL
    J Am Coll Cardiol; 2002 May; 39(10):1692-8. PubMed ID: 12020499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.